2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and Adenocarcinoma, Endometrioid

2-aminobicyclo(2,2,1)heptane-2-carboxylic acid has been researched along with Adenocarcinoma, Endometrioid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, LA; Holst, J; Lum, T; Marshall, AD; Otte, NJ; Rasko, JE; Thoeng, A; van Geldermalsen, M; Vellozzi, MA; Wang, Q; Zhang, BK	1

Other Studies

1 other study(ies) available for 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and Adenocarcinoma, Endometrioid

Article	Year
LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma. International journal of cancer, 2016, 12-01, Volume: 139, Issue:11 Topics: Amino Acids, Cyclic; Carcinoma, Endometrioid; Cell Growth Processes; Cell Line, Tumor; Endometrial Neoplasms; Female; Gene Knockdown Techniques; Humans; Large Neutral Amino Acid-Transporter 1; Molecular Targeted Therapy; RNA, Messenger; RNA, Small Interfering; Spheroids, Cellular	2016

Article

Year

LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.

International journal of cancer, 2016, 12-01, Volume: 139, Issue:11

Topics: Amino Acids, Cyclic; Carcinoma, Endometrioid; Cell Growth Processes; Cell Line, Tumor; Endometrial Neoplasms; Female; Gene Knockdown Techniques; Humans; Large Neutral Amino Acid-Transporter 1; Molecular Targeted Therapy; RNA, Messenger; RNA, Small Interfering; Spheroids, Cellular

2016